Page last updated: 2024-11-13

carboxyphthalato-1,2-diaminocyclohexaneplatinum

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carboxyphthalato-1,2-diaminocyclohexaneplatinum: RN given refers to hydrogen(SP-4-3(1R-trans))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID56840982
MeSH IDM0077515

Synonyms (8)

Synonym
nsc 271674
jm 82
carboxyphthalato-1,2-diaminocyclohexaneplatinum
4-carboxyphthalato(1,2-diaminocyclohexane)platinum (ii)
platinum(ii), (cyclohexane-1,2-diammine)(4-carboxyphthlato)-
(sp-4-3)-hydrogen (1,2,4-benzenetricarboxylato(3-)-o(1),o(2))(1,2-cyclohexanediamine-n,n') platinate(1-)
platinate (1-), (1,2,4-benzenetricarboxylato(3-)-o(sup 1),o(sup 2))(1,2-cyclohexanediamine-n,n')-, hydrogen, (sp-4-3)-
unii-918cg3eo0f

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Thus any enhancement in therapeutic efficacy with these second generation analogues can only be expected from possible decreases in toxic effects but not from superior tumor cell kill activity."( Comparative cytotoxicity between cisplatin and second generation platinum analogs.
Drewinko, B; Trujillo, JM; Yang, LY, 1985
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Nine dosage levels, ranging from 40 to 800 mg/sq m, were studied."( Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
Alcock, N; Burchenal, JH; Donner, A; Greene, G; Kelsen, DP; Leyland-Jones, B; Philips, FS; Scher, H; Tan, C; Williams, L; Young, CW, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.81 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews4 (33.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (58.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]